Post Transplant Study

NCT00395902 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Tansplant
Secondary Hyperparathyroidism
Hyperparathyroidism

Interventions

DRUG: Sensipar after Post Transplant

Sponsor

Amgen